Clinical Trials Browser

Osteosarcoma × Denosumab × Sarcoma × Clear all

NCT02470091 2024-01-22

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Phase 2 Completed

56 enrolled 18 charts

Osteosarcoma